In the absence of a submission from the holder of the marketing authorisation, busulfan (Busilvex®) cannot be endorsed for use within NHS Wales following fludarabine as conditioning treatment prior to haematopoietic progenitor cell transplantation in adult patients who are candidates for a reduced-intensity conditioning regimen.